Cyrus Daruwalla

4PUBLICATIONS
50CO-AUTHORS
Medical mycologyRegenerative medicine (incl. stem cells)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 24, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

|Dec 08, 2025
The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy.

Gioia Riboni-Verri, Christopher E McMurran, Trisha Mukherjee

|Feb 28, 2023
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.

Cyrus Daruwalla, Vahid Shaygannejad, Serkan Ozakbas

|Sep 18, 2022
Remyelination varies between and within lesions in multiple sclerosis following bexarotene.

J William L Brown, Ferran Prados, Daniel R Altmann

Pageof 1

Frequent Collaborators

3 joint publications

J William L Brown

3 joint publications

Nick G Cunniffe

3 joint publications

Alasdair J Coles

2 joint publications

Izanne Roos